{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-010192","form_type":"8-K","ticker":null,"cik":"0001838821","company_name":"ARYA Sciences Acquisition Corp IV","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.895858+00:00","generated_at":"2026-06-05T09:27:34.175818+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ARYA Sciences shareholders approve extension of merger deadline to Apr 2, 2024, with up to 12 monthly extensions","bullets":["Shareholders approved Extension Amendment: deadline moved to Apr 2, 2024, with up to 11 optional monthly extensions to Mar 2, 2025.","Sponsor to fund $111,000 per month into trust account for each extension month; Fourth Convertible Note available for funding.","Approved Class B Share Amendment: conversion to Class A shares before business combination, but no trust distribution rights.","Approved Redemption Limitation Amendment eliminating $5M net tangible asset minimum for redemptions.","390,815 Class A shares redeemed at ~$11.15/share for total ~$4.36M in connection with the vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-010192","json":"https://secwatch.observer/filing/0001140361-24-010192.json","markdown":"https://secwatch.observer/filing/0001140361-24-010192.md","text":"https://secwatch.observer/filing/0001140361-24-010192.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1838821/000114036124010192/0001140361-24-010192-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1838821/000114036124010192/ny20020899x11_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T09:27:34.175818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6cf0e04c437835c5c8e3b7ec9e7171ddfd1c7038","claim":"ARYA Sciences Acquisition Corp IV: Amended articles of association to extend business combination deadline from March 2, 2024 to April 2, 2024, with optional monthly extensions up to March 2, 2025 (effective 2024-02-27).","evidence_excerpt":"to approve an amendment to ARYA’s amended and restated memorandum and articles of association","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1838821/000114036124010192/0001140361-24-010192-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-02-27"}],"fact_type":"governance_change"},{"claim_id":"29595c477c39e1805568ecc5c8676665d3cca5d5","claim":"ARYA Sciences Acquisition Corp IV shareholders approved Class B Share Proposal at the 2024-02-27 meeting.","evidence_excerpt":"The Class B Share Proposal For Against Abstain 6,945,870 166,682 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1838821/000114036124010192/0001140361-24-010192-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-02-27"}],"fact_type":"shareholder_vote"},{"claim_id":"5414f331840b5cbeae0bfe6c86a19757d5274020","claim":"ARYA Sciences Acquisition Corp IV shareholders approved Redemption Limitation Amendment Proposal at the 2024-02-27 meeting.","evidence_excerpt":"The Redemption Limitation Amendment Proposal For Against Abstain 6,945,870 166,682 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1838821/000114036124010192/0001140361-24-010192-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-02-27"}],"fact_type":"shareholder_vote"},{"claim_id":"cf199439e683f8a4a9febd860a19a6a3a63b189b","claim":"ARYA Sciences Acquisition Corp IV shareholders approved Extension Amendment Proposal at the 2024-02-27 meeting.","evidence_excerpt":"The Extension Amendment Proposal For Against Abstain 6,903,671 208,881 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1838821/000114036124010192/0001140361-24-010192-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-02-27"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}